GHIRARDI, MARIA ANGELA
 Distribuzione geografica
Continente #
NA - Nord America 246
EU - Europa 125
AS - Asia 28
AF - Africa 4
Totale 403
Nazione #
US - Stati Uniti d'America 243
RU - Federazione Russa 60
SE - Svezia 17
IE - Irlanda 15
IT - Italia 15
CN - Cina 9
HK - Hong Kong 9
SG - Singapore 9
CZ - Repubblica Ceca 5
CI - Costa d'Avorio 4
FI - Finlandia 4
GB - Regno Unito 3
CA - Canada 2
CH - Svizzera 2
DE - Germania 2
JO - Giordania 1
MX - Messico 1
RO - Romania 1
UA - Ucraina 1
Totale 403
Città #
Santa Clara 142
Chandler 23
Dublin 15
Altamura 10
Lawrence 10
Ashburn 8
Singapore 8
Boston 5
Prague 5
Princeton 5
Abidjan 4
Buffalo 4
Helsinki 4
Hong Kong 4
Moscow 4
Shanghai 3
Acquaviva delle Fonti 2
Ann Arbor 2
Bern 2
Fairfield 2
Houston 2
London 2
Medford 2
Toronto 2
Bremen 1
Cambridge 1
Falkenstein 1
Florence 1
Genova 1
Hangzhou 1
Reston 1
San Diego 1
Scandicci 1
Shenzhen 1
Washington 1
Wilmington 1
Woodbridge 1
Yubileyny 1
Totale 284
Nome #
Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial 94
Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19 86
Long-term follow-up of recovered MPN patients with COVID-19 80
High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib 77
Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: Update of the ERNEST Study 71
Totale 408
Categoria #
all - tutte 1.541
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.541


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202228 0 0 0 0 0 0 0 11 1 2 4 10
2022/2023104 8 30 7 4 7 11 10 10 12 0 2 3
2023/202436 2 4 7 1 2 6 0 5 0 4 0 5
2024/2025240 3 17 18 34 110 58 0 0 0 0 0 0
Totale 408